214 related articles for article (PubMed ID: 29668937)
21. Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide.
Li C; Flynn RS; Grider JR; Murthy KS; Kellum JM; Akbari H; Kuemmerle JF
Inflamm Bowel Dis; 2013 Dec; 19(13):2829-39. PubMed ID: 24051933
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta1 and Smad7 in the regulation of IBD.
Monteleone G; Boirivant M; Pallone F; MacDonald TT
Mucosal Immunol; 2008 Nov; 1 Suppl 1():S50-3. PubMed ID: 19079231
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal Regulation Between Smad7 and Sirt1 in the Gut.
Sedda S; Franzè E; Bevivino G; Di Giovangiulio M; Rizzo A; Colantoni A; Ortenzi A; Grasso E; Giannelli M; Sica GS; Fantini MC; Monteleone G
Front Immunol; 2018; 9():1854. PubMed ID: 30147698
[TBL] [Abstract][Full Text] [Related]
24. Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.
Monteleone G; Neurath MF; Ardizzone S; Di Sabatino A; Fantini MC; Castiglione F; Scribano ML; Armuzzi A; Caprioli F; Sturniolo GC; Rogai F; Vecchi M; Atreya R; Bossa F; Onali S; Fichera M; Corazza GR; Biancone L; Savarino V; Pica R; Orlando A; Pallone F
N Engl J Med; 2015 Mar; 372(12):1104-13. PubMed ID: 25785968
[TBL] [Abstract][Full Text] [Related]
25. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis.
Fichtner-Feigl S; Fuss IJ; Young CA; Watanabe T; Geissler EK; Schlitt HJ; Kitani A; Strober W
J Immunol; 2007 May; 178(9):5859-70. PubMed ID: 17442970
[TBL] [Abstract][Full Text] [Related]
26. Daikenchuto, a Kampo medicine, regulates intestinal fibrosis associated with decreasing expression of heat shock protein 47 and collagen content in a rat colitis model.
Inoue K; Naito Y; Takagi T; Hayashi N; Hirai Y; Mizushima K; Horie R; Fukumoto K; Yamada S; Harusato A; Hirata I; Omatsu T; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Ichikawa H; Kokura S; Yoshikawa T
Biol Pharm Bull; 2011; 34(11):1659-65. PubMed ID: 22040876
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of excess collagen IαI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I(+/-) mice.
Mahavadi S; Flynn RS; Grider JR; Qiao LY; Murthy KS; Hazelgrove KB; Kuemmerle JF
Inflamm Bowel Dis; 2011 Mar; 17(3):711-9. PubMed ID: 20722057
[TBL] [Abstract][Full Text] [Related]
28. A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn’s disease.
Zorzi F; Calabrese E; Monteleone I; Fantini M; Onali S; Biancone L; Pallone F; Monteleone G
Aliment Pharmacol Ther; 2012 Nov; 36(9):850-7. PubMed ID: 22971085
[TBL] [Abstract][Full Text] [Related]
29. Substance P modulates colitis-associated fibrosis.
Koon HW; Shih D; Karagiannides I; Zhao D; Fazelbhoy Z; Hing T; Xu H; Lu B; Gerard N; Pothoulakis C
Am J Pathol; 2010 Nov; 177(5):2300-9. PubMed ID: 20889569
[TBL] [Abstract][Full Text] [Related]
30. NF-E2-Related Factor 2 Suppresses Intestinal Fibrosis by Inhibiting Reactive Oxygen Species-Dependent TGF-β1/SMADs Pathway.
Guan Y; Tan Y; Liu W; Yang J; Wang D; Pan D; Sun Y; Zheng C
Dig Dis Sci; 2018 Feb; 63(2):366-380. PubMed ID: 28815354
[TBL] [Abstract][Full Text] [Related]
31. Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease.
Ardizzone S; Bevivino G; Monteleone G
Therap Adv Gastroenterol; 2016 Jul; 9(4):527-32. PubMed ID: 27366221
[TBL] [Abstract][Full Text] [Related]
32. TGF-β1 signaling and Smad7 control T-cell responses in health and immune-mediated disorders.
Laudisi F; Stolfi C; Monteleone I; Monteleone G
Eur J Immunol; 2023 Nov; 53(11):e2350460. PubMed ID: 37611637
[TBL] [Abstract][Full Text] [Related]
33. Deletion of Smad7 Ameliorates Intestinal Inflammation and Contributes to Fibrosis.
Schuler C; Foti F; Perren L; Mamie C; Weder B; Stokmaier M; de Vallière C; Heuchel R; Ruiz PA; Rogler G; Hausmann M
Inflamm Bowel Dis; 2023 Apr; 29(4):647-660. PubMed ID: 36282601
[TBL] [Abstract][Full Text] [Related]
34. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
35. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
36. Dynamic progress of 2,4,6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model.
Zhu MY; Lu YM; Ou YX; Zhang HZ; Chen WX
J Dig Dis; 2012 Aug; 13(8):421-9. PubMed ID: 22788928
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D prevents the intestinal fibrosis via induction of vitamin D receptor and inhibition of transforming growth factor-beta1/Smad3 pathway.
Tao Q; Wang B; Zheng Y; Jiang X; Pan Z; Ren J
Dig Dis Sci; 2015 Apr; 60(4):868-75. PubMed ID: 25326845
[TBL] [Abstract][Full Text] [Related]
38. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
39. Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer.
Troncone E; Marafini I; Stolfi C; Monteleone G
Front Immunol; 2018; 9():1407. PubMed ID: 29973939
[TBL] [Abstract][Full Text] [Related]
40. Homocysteine promotes intestinal fibrosis in rats with trinitrobenzene sulfonic acid-induced colitis.
Ding H; Gan HZ; Fan WJ; Cao LY; Xu JM; Mei Q
Dig Dis Sci; 2015 Feb; 60(2):375-81. PubMed ID: 25293822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
